US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist
  • 20.270
  • -0.290-1.41%
Close Dec 13 16:00 ET
  • 20.270
  • 0.0000.00%
Post 16:20 ET
1.44BMarket Cap-6.99P/E (TTM)

Nurix Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2024
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2.54%-42.18M
-114.98%-39.71M
13.42%-41.95M
49.09%-81.37M
170.32%26.69M
11.18%-41.13M
43.89%-18.47M
-13.66%-48.45M
-89.42%-159.81M
-22.79%-37.96M
Net income from continuing operations
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-53.90%-180.36M
-23.91%-46.72M
Operating gains losses
----
----
----
6,077.78%556K
--12K
--448K
--40K
--56K
-92.97%9K
--0
Depreciation and amortization
22.52%4.15M
22.74%4.09M
22.26%3.89M
26.33%13.65M
23.71%3.76M
17.26%3.38M
26.63%3.33M
41.15%3.18M
77.70%10.81M
88.63%3.04M
Other non cash items
----
----
----
----
----
----
----
----
--201K
--0
Change In working capital
81.73%-2.7M
-12.04%-5.94M
45.14%-10.21M
205.78%20.12M
3,160.35%58.82M
-40.04%-14.78M
-319.02%-5.3M
-107.72%-18.62M
-308.73%-19.02M
-617.16%-1.92M
-Change in receivables
----
----
----
--0
--2M
----
----
----
354.45%6M
--0
-Change in prepaid assets
-127.93%-570K
-92.11%169K
171.79%1.17M
295.52%2.14M
-136.07%-417K
377.69%2.04M
214,300.00%2.14M
-7.46%-1.63M
79.90%-1.09M
93.31%1.16M
-Change in payables and accrued expense
103.92%7.13M
-49,468.42%-9.38M
140.94%2.66M
-37.42%4.74M
222.28%7.73M
481.06%3.5M
-99.76%19K
-90.15%-6.51M
-3.04%7.57M
-43.51%2.4M
-Change in other current liabilities
9.70%-1.68M
8.31%-1.63M
-11.98%-1.46M
-28.68%-6.27M
-11.41%-1.33M
-64.10%-1.86M
16.73%-1.78M
-219.12%-1.3M
5.31%-4.87M
56.05%-1.19M
-Change in other working capital
53.92%-7.59M
186.47%4.91M
-37.04%-12.59M
173.28%19.51M
1,287.02%50.84M
-77.21%-16.47M
39.81%-5.68M
-153.70%-9.18M
-286.86%-26.63M
-218.87%-4.28M
Cash from discontinued investing activities
Operating cash flow
-2.54%-42.18M
-114.98%-39.71M
13.42%-41.95M
49.09%-81.37M
170.32%26.69M
11.18%-41.13M
43.89%-18.47M
-13.66%-48.45M
-89.42%-159.81M
-22.79%-37.96M
Investing cash flow
Cash flow from continuing investing activities
-193.69%-21.34M
-399.03%-131.07M
121.02%35.51M
151.13%68.3M
-126.13%-14.37M
136.11%22.78M
1,019.85%43.83M
-59.86%16.07M
125.12%27.2M
250.61%55.01M
Net PPE purchase and sale
4.55%-2.35M
-79.35%-1.94M
-26.66%-2.88M
31.39%-8.4M
-0.78%-2.59M
28.06%-2.46M
61.28%-1.08M
34.42%-2.28M
-116.29%-12.24M
-197.56%-2.57M
Net investment purchase and sale
-175.26%-18.99M
-387.53%-129.13M
109.30%38.4M
94.47%76.7M
-120.47%-11.79M
142.30%25.23M
2,372.82%44.91M
-57.83%18.35M
138.45%39.44M
261.45%57.57M
Cash from discontinued investing activities
Investing cash flow
-193.69%-21.34M
-399.03%-131.07M
121.02%35.51M
151.13%68.3M
-126.13%-14.37M
136.11%22.78M
1,019.85%43.83M
-59.86%16.07M
125.12%27.2M
250.61%55.01M
Financing cash flow
Cash flow from continuing financing activities
2,586.03%45.77M
950,908.00%237.75M
9.66%1.62M
-97.25%3.22M
105.19%7K
-98.52%1.7M
-94.21%25K
-0.47%1.48M
-23.84%117.19M
-127.00%-135K
Net common stock issuance
--41.87M
----
----
--0
--0
--0
----
----
-87.08%19.4M
--0
Proceeds from stock option exercised by employees
128.76%3.9M
704.00%201K
9.66%1.62M
-96.71%3.22M
105.19%7K
-98.23%1.7M
-94.21%25K
-0.47%1.48M
2,525.29%97.79M
-127.00%-135K
Cash from discontinued financing activities
Financing cash flow
2,586.03%45.77M
950,908.00%237.75M
9.66%1.62M
-97.25%3.22M
105.19%7K
-98.52%1.7M
-94.21%25K
-0.47%1.48M
-23.84%117.19M
-127.00%-135K
Net cash flow
Beginning cash position
96.61%117.69M
47.12%50.71M
-15.06%55.53M
-19.08%65.38M
-10.84%43.21M
41.06%59.86M
-56.74%34.47M
-19.08%65.38M
-32.41%80.79M
-67.20%48.46M
Current changes in cash
-6.56%-17.75M
163.82%66.98M
84.42%-4.81M
36.13%-9.85M
-27.16%12.32M
-376.51%-16.65M
168.16%25.39M
-2,681.55%-30.9M
60.20%-15.42M
125.28%16.92M
End cash Position
131.33%99.95M
96.61%117.69M
47.12%50.71M
-15.06%55.53M
-15.06%55.53M
-10.84%43.21M
41.06%59.86M
-56.74%34.47M
-19.08%65.38M
-19.08%65.38M
Free cash flow
-2.14%-44.52M
-113.01%-41.64M
11.62%-44.84M
47.83%-89.77M
159.49%24.1M
12.34%-43.59M
45.25%-19.55M
-10.04%-50.73M
-91.11%-172.05M
-27.53%-40.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2024(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2.54%-42.18M-114.98%-39.71M13.42%-41.95M49.09%-81.37M170.32%26.69M11.18%-41.13M43.89%-18.47M-13.66%-48.45M-89.42%-159.81M-22.79%-37.96M
Net income from continuing operations -32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-53.90%-180.36M-23.91%-46.72M
Operating gains losses ------------6,077.78%556K--12K--448K--40K--56K-92.97%9K--0
Depreciation and amortization 22.52%4.15M22.74%4.09M22.26%3.89M26.33%13.65M23.71%3.76M17.26%3.38M26.63%3.33M41.15%3.18M77.70%10.81M88.63%3.04M
Other non cash items ----------------------------------201K--0
Change In working capital 81.73%-2.7M-12.04%-5.94M45.14%-10.21M205.78%20.12M3,160.35%58.82M-40.04%-14.78M-319.02%-5.3M-107.72%-18.62M-308.73%-19.02M-617.16%-1.92M
-Change in receivables --------------0--2M------------354.45%6M--0
-Change in prepaid assets -127.93%-570K-92.11%169K171.79%1.17M295.52%2.14M-136.07%-417K377.69%2.04M214,300.00%2.14M-7.46%-1.63M79.90%-1.09M93.31%1.16M
-Change in payables and accrued expense 103.92%7.13M-49,468.42%-9.38M140.94%2.66M-37.42%4.74M222.28%7.73M481.06%3.5M-99.76%19K-90.15%-6.51M-3.04%7.57M-43.51%2.4M
-Change in other current liabilities 9.70%-1.68M8.31%-1.63M-11.98%-1.46M-28.68%-6.27M-11.41%-1.33M-64.10%-1.86M16.73%-1.78M-219.12%-1.3M5.31%-4.87M56.05%-1.19M
-Change in other working capital 53.92%-7.59M186.47%4.91M-37.04%-12.59M173.28%19.51M1,287.02%50.84M-77.21%-16.47M39.81%-5.68M-153.70%-9.18M-286.86%-26.63M-218.87%-4.28M
Cash from discontinued investing activities
Operating cash flow -2.54%-42.18M-114.98%-39.71M13.42%-41.95M49.09%-81.37M170.32%26.69M11.18%-41.13M43.89%-18.47M-13.66%-48.45M-89.42%-159.81M-22.79%-37.96M
Investing cash flow
Cash flow from continuing investing activities -193.69%-21.34M-399.03%-131.07M121.02%35.51M151.13%68.3M-126.13%-14.37M136.11%22.78M1,019.85%43.83M-59.86%16.07M125.12%27.2M250.61%55.01M
Net PPE purchase and sale 4.55%-2.35M-79.35%-1.94M-26.66%-2.88M31.39%-8.4M-0.78%-2.59M28.06%-2.46M61.28%-1.08M34.42%-2.28M-116.29%-12.24M-197.56%-2.57M
Net investment purchase and sale -175.26%-18.99M-387.53%-129.13M109.30%38.4M94.47%76.7M-120.47%-11.79M142.30%25.23M2,372.82%44.91M-57.83%18.35M138.45%39.44M261.45%57.57M
Cash from discontinued investing activities
Investing cash flow -193.69%-21.34M-399.03%-131.07M121.02%35.51M151.13%68.3M-126.13%-14.37M136.11%22.78M1,019.85%43.83M-59.86%16.07M125.12%27.2M250.61%55.01M
Financing cash flow
Cash flow from continuing financing activities 2,586.03%45.77M950,908.00%237.75M9.66%1.62M-97.25%3.22M105.19%7K-98.52%1.7M-94.21%25K-0.47%1.48M-23.84%117.19M-127.00%-135K
Net common stock issuance --41.87M----------0--0--0---------87.08%19.4M--0
Proceeds from stock option exercised by employees 128.76%3.9M704.00%201K9.66%1.62M-96.71%3.22M105.19%7K-98.23%1.7M-94.21%25K-0.47%1.48M2,525.29%97.79M-127.00%-135K
Cash from discontinued financing activities
Financing cash flow 2,586.03%45.77M950,908.00%237.75M9.66%1.62M-97.25%3.22M105.19%7K-98.52%1.7M-94.21%25K-0.47%1.48M-23.84%117.19M-127.00%-135K
Net cash flow
Beginning cash position 96.61%117.69M47.12%50.71M-15.06%55.53M-19.08%65.38M-10.84%43.21M41.06%59.86M-56.74%34.47M-19.08%65.38M-32.41%80.79M-67.20%48.46M
Current changes in cash -6.56%-17.75M163.82%66.98M84.42%-4.81M36.13%-9.85M-27.16%12.32M-376.51%-16.65M168.16%25.39M-2,681.55%-30.9M60.20%-15.42M125.28%16.92M
End cash Position 131.33%99.95M96.61%117.69M47.12%50.71M-15.06%55.53M-15.06%55.53M-10.84%43.21M41.06%59.86M-56.74%34.47M-19.08%65.38M-19.08%65.38M
Free cash flow -2.14%-44.52M-113.01%-41.64M11.62%-44.84M47.83%-89.77M159.49%24.1M12.34%-43.59M45.25%-19.55M-10.04%-50.73M-91.11%-172.05M-27.53%-40.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List